CIPO Patents = 1

EPO Patents = 5

Trademarks = 2

Forward Citations = 110

Loading Chart...

4 inventors (with patents filed for the assignee):

Hiroaki Shizuya (20 out of 24 patents)

Larry L Green (20 out of 71 patents)

Dana Duey (2 out of 3 patents)

4. John Lippincott (2 out of 9 patents)

22 patents: Sort by Forward Citations

1. 11753478 - Anti-CD115 antibodies (2023-09-12),

2. 11352444 - Genetic engineering of non-human animals for the production of chimeric antibodies (2022-06-07),

3. 11242409 - Genetic engineering of non-human animals for the production of chimeric antibodies (2022-02-08),

4. 11220555 - Genetic engineering of non-human animals for the production of chimeric antibodies (2022-01-11),

5. 11104744 - Genetic engineering of non-human animals for the production of chimeric antibodies (2021-08-31),

6. 11104743 - Genetic engineering of non-human animals for the production of chimeric antibodies (2021-08-31),

7. 10836832 - Genetic engineering of non-human animals for the production of chimeric antibodies (2020-11-17),

8. 10829564 - Genetic engineering of non-human animals for the production of chimeric antibodies (2020-11-10),

9. 10759861 - Anti-CD115 antibodies (2020-09-01),

10. 10662255 - Genetic engineering of non-human animals for the production of chimeric antibodies (2020-05-26),

11. 10638736 - Non-human mammals for the production of chimeric antibodies (2020-05-05),

12. 10626188 - Genetic engineering of non-human animals for the production of chimeric antibodies (2020-04-21),

13. 10618977 - Genetic engineering of non-human animals for the production of chimeric antibodies (2020-04-14),

14. 10604587 - Genetic engineering of non-human animals for the production of chimeric antibodies (2020-03-31),

15. 10575504 - Non-human mammals for the production of chimeric antibodies (2020-03-03),

Company Overview

Ablexis, LLC is a biotechnology company based in San Diego, California, specializing in the development of advanced antibody discovery technologies. The company focuses on creating innovative solutions for therapeutic antibody development, leveraging its proprietary platform to enhance the efficiency and effectiveness of the drug discovery process. With a commitment to advancing biopharmaceuticals, Ablexis collaborates with various partners to bring novel treatments to market, addressing critical medical needs across multiple therapeutic areas.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

22 Patents

#274 in San Diego, CA

#3,590 in California

#15,051 in US

#28,807 in the World

San Diego, CA, United States of America

Ablexis, LLC

Forward Citations = 110

4 inventors:

Hiroaki Shizuya (20 out of 24 patents)

Larry L Green (20 out of 71 patents)

Dana Duey (2 out of 3 patents)

4. John Lippincott (2 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ablexis, LLC. Retrieved from https://idiyas.com/company/ablexis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]